Table of Contents Table of Contents
Previous Page  554 / 1096 Next Page
Information
Show Menu
Previous Page 554 / 1096 Next Page
Page Background

S539

ESTRO 36

_______________________________________________________________________________________________

isolated from blood drawns harvested before the

administration of the first fractioned dose of RT and 24 h

later. 4. Statistical analysis: Anova test is performed to

analyse the differential expression across IRS classes and

a Spearman analysis is performed to assess correlation

between expression and IRS index.

Results

The expression of

DDB2, GADD45A, CDKN1A,

and

ATM

genes following irradiation

2,3

has been correlated with the

in vitro

IRS evaluated by the G2-chromosomal assay; at

present, a positive correlation between

ATM

expression

and IRS could be inferred despite the unavoidable inter-

individual variability. The analyses on other DDR genes are

in progress.

Conclusion

The innovation of this study is the use of a molecular

biology approach to assess patient radiosensitivity before

RT, in the frame of an integrated approach between

clinicians and biologists.

References

1. Pantelias GE. & Terzoudi G. I.

Radiother. Oncol.

101

(2011).

2. Mognato M. & Celotti L.

Mutat. Res. Mol. Mech.

Mutagen.

578

(2005).

3. Girardi C.

et al.

PLoS One

7

(2012).

Poster: Radiobiology track: Radiobiology of lung cancer

PO-0975 Clinical utilization of the radiation-hypoxia-

induced abscopal/bystander effect in lung cancer

S. Tubin

1,2

, S. Gupta

3

, A.M. Mansoor

4

1

KABEG Klinikum Klagenfurt, Radioonkologie, Klagenfurt,

Austria

2

Sylvester Comprehensive Cancer Center- University of

Miami Leonard Miller School of Medicine, Department of

Radiation Oncology, Miami, USA

3

Georgia Cancer Center- Augusta University- Augusta-

GA- USA, Health Sciences, Augusta, USA

4

National Cancer Institute- National Institutes of Health,

Radiotherapy Development Branch- Radiation Research

Program- Division of Cancer Treatment and Diagnosis,

Rockville, USA

Purpose or Objective

To report on initial results in a small series of consecutive

patients treated with high-dose hypofractioneted

radiotherapy (1-3 fractions) in the treatment of

oligometastatic patients with large tumor masses focusing

on application of results previously obtained by in vitro

studies on radiation-induced abscopal/bystander effect.

Our previous study (unpublished data) focused on

targeting tumor hypoxia that induced a strong

abscopal/bystander effect. We provide data that support

the contention that high-dose radiation to the part of a

large gross tumor volume (GTV) has the potency to induce

a robust bystander effect, as well as abscopal (distant)

effects.

Material and Methods

In the in vitro studies conditioned medium-transfer

experiments with A-549, H-460 lung cancer cells, as well

as their hypoxic clones (A-549HR, H-460HR), were

performed. All the cells were irradiated in normoxic or

hypoxic conditions with 10Gy single dose and cell growth

and survival were monitored by real time cell electronic

sensing (RTCES) System and colony forming assay,

respectively. In the clinical study, 5 consecutive

oligometastatic patients with large hypoxic cancers of

lung (3), neck (1) and mediastinum (1) were treated with

high dose radiotherapy using high-energy photons. All

lesions were irradiated partially by targeting the central

hypoxic region (Figure 1), which corresponded to 30% of

total GTV (Mean GTV volume 181 cc, mean diameter 6, 8

cm) with 10Gy single fraction prescribed to the 70%

isodose line (Dmax 14 Gy). No patient got

chemotherapy/immune therapy.

Results

10Gy- in vitro induced abscopal effect in hypoxic

conditions was very effective in inducing growth delay of

both, unirradiated normoxic and hypoxic lung cancer cells

(Table 1), so we moved forward with clinical application

of bystander/abscopal effect. In all the treated patients,

a significant bystander effect after mean time of 3 weeks

and in 1 of the patients significant abscopal effect was

also observed (Figure 2). Overall response rates for

symptom relief and mass response were 100% (1 complete

and 4 good partial response).No patient experienced acute

or late toxicity of any grade.

Conclusion

Considering

the clinical benefit/toxicity ratio, the clinical

exploitation

of

biological

properties

of

bystander/abscopal effect induced by partial irradiation

of large tumor masses, and almost any dose distribution to

the normal tissue outside the irradiated tumor, could

make bystander/abscopal effect at least more effective

than conventional radiation therapy for treatment of

advanced cancers and the perfect treatment option for

symptomatic patient. Further, by inducing the distal

responses, like in the case of one of the patients,